Analyzing Viemed Healthcare (NASDAQ:VMD) & Labcorp (NYSE:LH)

Viemed Healthcare (NASDAQ:VMD) and Labcorp (NYSE:LH) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Earnings & Valuation

This table compares Viemed Healthcare and Labcorp”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viemed Healthcare	$301.61 million	1.22	$14.93 million	$0.36	26.86
Labcorp	$13.95 billion	2.10	$876.50 million	$12.19	29.69

Labcorp has higher revenue and earnings than Viemed Healthcare. Viemed Healthcare is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

74.2% of Viemed Healthcare shares are owned by institutional investors. Comparatively, 95.9% of Labcorp shares are owned by institutional investors. 20.6% of Viemed Healthcare shares are owned by company insiders. Comparatively, 0.8% of Labcorp shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Viemed Healthcare and Labcorp’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Viemed Healthcare	4.81%	10.16%	7.22%
Labcorp	6.88%	17.13%	7.96%

Volatility & Risk

Viemed Healthcare has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Comparatively, Labcorp has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Viemed Healthcare and Labcorp, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viemed Healthcare	0	3	1	0	2.25
Labcorp	0	3	7	1	2.82

Viemed Healthcare currently has a consensus target price of $14.00, indicating a potential upside of 44.78%. Labcorp has a consensus target price of $365.67, indicating a potential upside of 1.02%. Given Viemed Healthcare’s higher possible upside, research analysts clearly believe Viemed Healthcare is more favorable than Labcorp.

Summary

Labcorp beats Viemed Healthcare on 11 of the 15 factors compared between the two stocks.

About Viemed Healthcare

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

About Labcorp

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.